ELAC2 anticorps
Aperçu rapide pour ELAC2 anticorps (ABIN7002136)
Antigène
Voir toutes ELAC2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Attributs du produit
- Polyclonal Antibody
-
Purification
- Affinity purification
-
Immunogène
- Recombinant protein of human ELAC2
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:500-1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.7 mg/mL
-
Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- ELAC2 (ElaC Homolog 2 (ELAC2))
-
Autre désignation
- ELAC2
-
Sujet
- The protein encoded by this gene has a C-terminal domain with tRNA 3′, processing endoribonuclease activity, which catalyzes the removal of the 3' trailer from precursor tRNAs. The protein also interacts with activated Smad family member 2 (Smad2) and its nuclear partner forkhead box H1 (also known as FAST-1), and reduced expression can suppress transforming growth factor-beta induced growth arrest. Mutations in this gene result in an increased risk of prostate cancer. Multiple transcript variants encoding different isoforms have been found for this gene.
-
Poids moléculaire
- 92 kDa
-
UniProt
- Q9BQ52
Antigène
-